Portal Hypertension Completed Phase 2 Trials for Ribavirin (DB00811)

Also known as: Hypertension Portal / Hypertension, Portal / Portal hypertensions

IndicationStatusPhase
DBCOND0029015 (Portal Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01687257Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver DecompensationTreatment